Pharmaceutical Industry

Is the
current model fit for purpose?

These are symptoms of a decline of the pre-digital era model of medicinal product development. Our pharmaceutical industry members are those who are committed to moderninsing their product development to create safer and more effective medicinal products. 

Modernisation of the pharmaceutical industry requires a coresponding moderninsation of the way in which medicinal products are brought on to the market and the design of clinical trials. The Avicenna Alliance is working to promote modelling and simulation as a means of addressing the high cost of research and the uptake of in silico methods.

Avicenna Alliance news

Commission participates  to international In Silico Toxicology Protocol initiative

The European Commission’s Joint Research Center (JRC) Directorate published on 22 November an article highlighting...

find out more ›

Health Tech Industry roundtable meeting discussed EU Digital Health Agenda

On 15 October, a high-level roundtable meeting, organised by European Commissioner for Digital Economy and Society Mariya...

find out more ›

EU invests €1 billion in world-class European supercomputers

The Competitiveness Council (Council of Ministers) of the European Union adopted a Regulation to establish a Joint Undertaking of European...

find out more ›

Show all activites